The implication of the polymorphisms of COX-1, UGT1A6, and CYP2C9 among cardiovascular disease patients treated with aspirin

Purpose. Enzymes potentially responsible for the pharmacokinetic variations of aspirin include cyclooxygenase-1 (COX-1), UDP-glucuronosyltransferase (UGT1A6) and P450 (CYP) (CYP2C9). We therefore aimed to determine the types and frequencies of variants of COX-1 (A-842G), UGT1A6 (UGT1A6*2; A541G and...

Full description

Bibliographic Details
Main Authors: Abdul Jalil, N.J (Author), Ali, O. (Author), Azreen, N.I (Author), Bannur, Z. (Author), Darinah, N. (Author), Derahman, A. (Author), Gunasekaran (Author), Hamidi, H. (Author), Kek, T.L (Author), Maskon, O. (Author), Rafizi, M. (Author), Salleh, M.Z (Author)
Format: Article
Language:English
Published: Canadian Society for Pharmaceutical Sciences 2015
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus